Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Optimal Dose of Remifentanil Required to Ensure Apnoea During Magnetic Resonance Imaging of the Heart Under General Anaesthesia

NCT02481791 is registered in ClinicalTrials.gov with Alder Hey Children's NHS Foundation Trust as lead sponsor.

NCT NCT02481791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02481791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Optimal Dose of Remifentanil Required to Ensure Apnoea During Magnetic Resonance Imaging of the Heart Under General Anaesthesia
Lead sponsor
Alder Hey Children's NHS Foundation Trust
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2015
Completion date
December 31, 2019
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaesthesia, children, heart diseases, magnetic resonance imaging